It is possible that VEGF-A is more significantly elevated in adenocarcinoma than in squamous cell cervical cancer, and it could be related to its more aggressive behavior and poor survival, as well as poor response to adjuvant therapy [10,15,17]. This evidence concerns the gene VEGFA and cervical squamous cell carcinoma.